Option Chain

Climb Bio Inc

CLYMNASDAQ · USD

11.89USD0.00 (-5.04%)

2510

Climb Bio Inc (CLYM) Option Chain

As of September 23, 2026, Climb Bio Inc is trading at $11.89, a -5.04% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 113.2%. IV Rank is —%.

Tracking the CLYM option chain helps you see every strike and expiry on Climb Bio Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Climb Bio Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CLYM options activity at a glance. Use our scanner to monitor the CLYM option chain in real time and filter for the CLYM options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CLYM stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CLYM option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CLYM stock options are being actively traded and where they are not.

Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Climb Bio Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CLYM options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CLYM stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

IndustryBiotechnology
SectorHealthcare
IV percentile—
Market cap (M$)683
52 weeks high-35.13%
52 weeks low672.08%
Analyst recommendationStrong Buy
1.06
Target price$27.47
131.03% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-11-11
P/E—
Future P/E—
EPS (ttm)-0.83
EPS growth next 5 years-16.11%

As of September 23, 2026

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
7.89	7	0	1.61	4.39	4.50	7.50	7.50	-40.10	—	0.35	0.00	0.35	24	1	92.11
29.73	1,013	7	1.26	1.89	2.80	3.50	10.00	-20.13	—	0.75	0.00	0.75	0	518	70.27
56.00	12	4	1.78	0.00	1.25	2.30	12.50	-0.16	1.00	2.00	0.61	0.89	14	2,160	44.00
76.08	264	7	0.55	0.00	0.40	0.70	15.00	+19.81	2.55	3.70	3.11	0.02	0	23	23.92
88.12	13	0	0.50	0.00	—	0.50	17.50	+39.78	3.10	5.90	5.61	-1.11	0	26	11.88

As of September 23, 2026

Browse all Option Chain tickers

Stock Statistics

Scan the full option chain in one place